Hit enter to search or ESC to close
ERA4TBERA4TBERA4TB
  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
  • Results
  • TB Facts
  • SharePoint
Category

Event

Event

Consortium Meeting

On January 26th and 27th the second Consortium Meeting took place online to share the…
Inari Soininen
Inari SoininenFebruary 2, 2021
Event

ERA4TB Kick off Meeting

The European Regimen Accelerator For Tuberculosis (ERA4TB) Consortium meet in Madrid during two full days…
admin
adminJanuary 28, 2020

Recent Posts

  • Consortium Meeting
  • Europa Press Digital Meetings: AIDS, tuberculosis and malaria in times of COVID-19
  • ERA4TB at the Union World Conference
  • The potential impact of the Covid-19 response on tuberculosis in high-burden countries: a modelling analysis
  • ERA4TB Press Release

Categories

  • Event
  • News
  • Press

TWITTER

IMI_ERA4TBFollow

European Regimen Accelerator for Tuberculosis. Grant Agreement number: 853989 — ERA4TB

IMI_ERA4TB
Retweet on TwitterIMI_ERA4TB Retweeted
8 Feb

The 2-day @AMR_Combine webinar on how to improve clinical trial designs and analysis in vaccine development for #AMR pathogens is starting now with an amazing panel of experts https://amr-accelerator.eu/event/expert-workshop-on-vaccines-for-amr-pathogens/ #AntibioticResistane #FightAMR #TogetherAgainstAMR

Reply on Twitter 1358786227303047173Retweet on Twitter 13587862273030471738Like on Twitter 13587862273030471738Twitter 1358786227303047173
Retweet on TwitterIMI_ERA4TB Retweeted
30 Jan 2020

💥 Investigadores españoles lideran un gran proyecto internacional para desarrollar nuevos antibióticos contra la #tuberculosis

👏 El proyecto surge de la alianza entre la @EFPIA y la UE para crear nuevos #medicamentos: @IMI_ERA4TB

Lo cuenta @el_pais 👉 https://elpais.com/elpais/2020/01/28/planeta_futuro/1580247231_991237.html

Reply on Twitter 1222823517697110016Retweet on Twitter 12228235176971100165Like on Twitter 122282351769711001610Twitter 1222823517697110016
Retweet on TwitterIMI_ERA4TB Retweeted
3 Feb

A pleasure to be part of the ERA4TB consortium and a succesful Consortium meeting! #imi_ERA4TB #MID3 #tuberculosis https://twitter.com/IMI_ERA4TB/status/1354490079541137411

IMI_ERA4TB@IMI_ERA4TB

Near 150 people connected during our Consortium Meeting! Thank you everyone for the strong contributions in these two days of productive discussions. Now we're ready to face a challenging but hopefully successful 2nd year of the project!

#imi_era4tb #tuberculosis @AMRAccelerator

Reply on Twitter 1357012387170316292Retweet on Twitter 13570123871703162923Like on Twitter 13570123871703162929Twitter 1357012387170316292
27 Jan

Near 150 people connected during our Consortium Meeting! Thank you everyone for the strong contributions in these two days of productive discussions. Now we're ready to face a challenging but hopefully successful 2nd year of the project!

#imi_era4tb #tuberculosis @AMRAccelerator

Reply on Twitter 1354490079541137411Retweet on Twitter 135449007954113741110Like on Twitter 135449007954113741127Twitter 1354490079541137411
Retweet on TwitterIMI_ERA4TB Retweeted
26 Jan

Excellent first day of our @IMI_ERA4TB Consortium Meeting. Impressive progress made across the project work packages despite all the challenges faced in 2020!

Thanks @SynapseManagers for excellent organisation!
#TB #DrugDevelopment @NICEComms @DrPJonsson https://twitter.com/IMI_ERA4TB/status/1353744039724666880

IMI_ERA4TB@IMI_ERA4TB

Everything's ready for the next Consortium Meeting!

We will share the overall developments during the first year of project implementation and discuss on critical topics for TB Research

#imi_era4tb #tuberculosis @AMRAccelerator

Reply on Twitter 1354159566968270849Retweet on Twitter 13541595669682708493Like on Twitter 13541595669682708498Twitter 1354159566968270849
Load More...
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2021 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.